(Updated - December 19, 2022 7:04 AM EST)

Jefferies analyst Michael Yee upgraded Moderna (NASDAQ: MRNA) from Hold to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE